AbbVie reports Q2 revenue of $16,990 million versus estimate of $16,765 million; adjusted EPS $3.65 versus estimate $3.60.
FirstSquawk07/31, 06:47 PM
- Q2 GLOBAL SKYRIZI REVENUE USD 5,505 MILLION
- Q2 GLOBAL RINVOQ REVENUE USD 2,525 MILLION
- Q2 GLOBAL HUMIRA REVENUE USD 756 MILLION
- Q2 ADJUSTED EPS USD 3.65
Figures as quoted by FirstSquawk
Related assets
Coming up for ABBV
Explore next
Latest ABBV news
FirstSquawk08/20, 09:57 AM
Piper Sandler raised its price target on AbbVie to $303 from $298.
Bloomberg08/17, 06:28 PM
Bloomberg08/03, 04:58 PM